Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain (COVID19@Spain)
Characteristics and Predictors of Death Among Hospitalized Patients With COVID-19 in Spain
Sponsor: Fundacion SEIMC-GESIDA
This observational or N/A phase trial investigates Covid19 and is currently completed. Fundacion SEIMC-GESIDA leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Aug 2023 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Aug 2023 [monthly]
Completed
▶ Show 2 earlier versions
-
Jun 2020 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
May 2020 — Jun 2020 [monthly]
Active Not Recruiting
First recorded
Mar 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundacion SEIMC-GESIDA
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
A Coruña, Spain , Alcañiz, Spain , Alicante, Spain , Alzira, Spain , Aranda de Duero, Spain , Arrasate / Mondragón, Spain , Arrecife, Spain , Barcelona, Spain , Benidorm, Spain , Bilbao, Spain and 67 more locations